These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30364238)

  • 1. The diluted atropine for inhibition of myopia progression in Korean children.
    Moon JS; Shin SY
    Int J Ophthalmol; 2018; 11(10):1657-1662. PubMed ID: 30364238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
    Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
    Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropine for the treatment of childhood myopia.
    Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
    Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of myopia onset with 0.025% atropine in premyopic children.
    Fang PC; Chung MY; Yu HJ; Wu PC
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of treatment response about low-dose (0.01%) atropine eye-drops in myopic children.
    Jeon GS; Hong IH; Lee JH; Song TG; Lee TY; Han JR
    Eur J Ophthalmol; 2022 Jul; 32(4):2011-2017. PubMed ID: 34399596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia.
    Clark TY; Clark RA
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):541-5. PubMed ID: 26218150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.
    Gong Q; Janowski M; Luo M; Wei H; Chen B; Yang G; Liu L
    JAMA Ophthalmol; 2017 Jun; 135(6):624-630. PubMed ID: 28494063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different concentrations of atropine on controlling myopia in myopic children.
    Shih YF; Chen CH; Chou AC; Ho TC; Lin LL; Hung PT
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):85-90. PubMed ID: 10048351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis.
    Gan J; Li SM; Wu S; Cao K; Ma D; He X; Hua Z; Kang MT; Wei S; Bai W; Wang N
    Front Med (Lausanne); 2021; 8():756398. PubMed ID: 35096861
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
    Long H; Shi MH; Li X
    J Fr Ophtalmol; 2023 Oct; 46(8):929-940. PubMed ID: 37147148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
    Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
    Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
    Chia A; Lu QS; Tan D
    Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial.
    Zhu Q; Tang GY; Hua ZJ; Xue LP; Zhou Y; Zhang JY; Zhu YT; Zhang XF
    Int J Ophthalmol; 2023; 16(6):939-946. PubMed ID: 37332542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis.
    Hou P; Wu D; Nie Y; Wei H; Liu L; Yang G
    Front Pharmacol; 2023; 14():1227787. PubMed ID: 37767401
    [No Abstract]   [Full Text] [Related]  

  • 16. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
    Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
    Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for rapid axial length elongation with low concentration atropine for myopia control.
    Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Yu S; Cui C; Lyu Y
    Sci Rep; 2021 Jun; 11(1):11729. PubMed ID: 34083576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effect of 0.01% atropine sulphate eye gel on myopia progression in children.
    Pan SY; Wang YZ; Li J; Zhang XH; Wang J; Zhu XP; Xiao XH; Liu JT
    Int J Ophthalmol; 2022; 15(7):1122-1127. PubMed ID: 35919322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retarding progression of myopia with seasonal modification of topical atropine.
    Lu PC; Chen JC
    J Ophthalmic Vis Res; 2010 Apr; 5(2):75-81. PubMed ID: 22737334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study.
    Lee CY; Sun CC; Lin YF; Lin KK
    BMC Ophthalmol; 2016 Jul; 16():114. PubMed ID: 27435576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.